Bioventus Inc. (BVS)

NMS – Real Time Price. Currency in USD

9.78

+0.05 (0.51%)

At close: Jun 26, 2026, 4:00 PM EDT

9.62

-0.16 (-1.63%)

After-hours: Jun 26, 2026, 6:32 PM EDT

09.06.2026

Are Investors Undervaluing Bioventus (BVS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

08.06.2026

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus NASDAQ: BVS executives outlined the company's portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT.

08.06.2026

Bioventus Inc. (BVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

02.06.2026

After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)

The heavy selling pressure might have exhausted for Bioventus (BVS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

02.06.2026

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026, at 4:00 p.m. ET.

29.05.2026

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Bioventus (BVS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

21.05.2026

Is Bioventus (BVS) Stock Undervalued Right Now?

Videos

No Data

There is no data to display

Press releases

06.05.2026

Bioventus Reports First Quarter Financial Results

DURHAM, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three months ended March 28, 2026.

05.03.2026

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

Q4 reported revenue of $157.9 million increased 2.8% and organic* revenue increased 10.0% Fourth quarter GAAP earnings of $0.21 per diluted share compared to $0.00 in the prior-year period Non-GAAP earnings* of $0.24 per diluted share Fourth quarter cash from operations of $38.0 million increased 97% 2026 financial guidance reflects continued above-market revenue growth, higher earnings and robust cash generation DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced fourth quarter and full-year financial results for the year ended December 31, 2025, and provided its financial guidance for full-year 2026.

05.12.2025

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Bioventus Inc. (NASDAQ: BVS) breached their fiduciary duties to shareholders.

04.11.2025

Bioventus Reports Third Quarter Financial Results

DURHAM, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three and nine months ended September 27, 2025.

Bioventus Inc. (BVS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bioventus Inc. (BVS)

Are Investors Undervaluing Bioventus (BVS) Right Now?

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus Inc. (BVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Is Bioventus (BVS) Stock Undervalued Right Now?

Videos

No Data

Press releases

Bioventus Reports First Quarter Financial Results

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Bioventus Reports Third Quarter Financial Results

Are Investors Undervaluing Bioventus (BVS) Right Now?

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus Inc. (BVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Is Bioventus (BVS) Stock Undervalued Right Now?

Videos

No Data

Press releases

Bioventus Reports First Quarter Financial Results

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Bioventus Reports Third Quarter Financial Results

Search stocks

Bioventus Inc. (BVS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bioventus Inc. (BVS)

Are Investors Undervaluing Bioventus (BVS) Right Now?

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus Inc. (BVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Is Bioventus (BVS) Stock Undervalued Right Now?

Videos

No Data

Press releases

Bioventus Reports First Quarter Financial Results

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Bioventus Reports Third Quarter Financial Results

Are Investors Undervaluing Bioventus (BVS) Right Now?

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus Inc. (BVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Is Bioventus (BVS) Stock Undervalued Right Now?

Videos

No Data

Press releases

Bioventus Reports First Quarter Financial Results

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Bioventus Reports Third Quarter Financial Results